Reistone Biopharma Company Limited
Clinical trials sponsored by Reistone Biopharma Company Limited, explained in plain language.
-
New pill aims to cut dangerous COPD attacks in half
Disease control Recruiting nowThis study tests an experimental tablet called RSS0343 in people with chronic obstructive pulmonary disease (COPD). The goal is to see if it can safely reduce the number of moderate or severe flare-ups over 48 weeks. About 237 adults aged 40–80 with COPD will take either the drug…
Phase: PHASE2 • Sponsor: Reistone Biopharma Company Limited • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
First human tests begin for potential bronchiectasis drug
Knowledge-focused Recruiting nowThis is a very early-stage study to check the safety of a new oral drug called RSS0343 and see how the body processes it. The study will involve 48 healthy volunteers who will take the drug or a placebo for several days. Researchers will closely monitor for side effects and measu…
Phase: PHASE1 • Sponsor: Reistone Biopharma Company Limited • Aim: Knowledge-focused
Last updated Apr 17, 2026 16:10 UTC